Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer
- 1 September 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (9) , 1437-1442
- https://doi.org/10.1016/0959-8049(95)00196-p
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A NEW BIOCHEMICAL MARKER FOR JOINT INJURY. ANALYSIS OF YKL-40 IN SERUM AND SYNOVIAL FLUIDRheumatology, 1993
- The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancerScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Identification of proteins secreted by human osteoblastic cells in cultureJournal of Bone and Mineral Research, 1992
- The pattern of metastases in human breast cancer: Methodological aspects and influence of prognostic factorsCancer Treatment Reviews, 1990
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Serum osteocalcin levels in breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1989
- Osteocalcin: a potential marker of metastatic bone disease and response to treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Isolation and characterization of a novel 39 kilodaton whey protein from bovine mammary secretions collected during the nonlactating periodBiochemical and Biophysical Research Communications, 1988
- Serum osteocalcin (BGP) in tumor-associated hypercalcemiaJournal of Bone and Mineral Research, 1986
- Carcinoembryonic antigen in breast cancer. Clinical reviewThe American Journal of Medicine, 1986